Skincare Company Dismissed Without Prejudice from Patent Infringement Lawsuit Filed by Allergan, Inc.

Share Article

DermaQuest Skin Therapy's Lash-Conditioning Product Proven Free of Drugs in Formula and Dismissed from Patent Infringement Case Filed by Allergan.

DermaQuest Skin Therapy, one of the 7 companies sued by Allergan, Inc. in a patent infringement case no. SACV07-1316 JVS over a prostaglandin-based ingredient, was dismissed from the suit by certified letter from Allergan on December 6, 2007. The lash conditioning product sold by DermaQuest Skin Therapy named DermaLash, is sold to the professional skincare market, and was found after inspection by Allergan not to contain any ingredients or drugs infringing on their patent of Lumigan.

"Upon notification of the lawsuit by Allergan, DermaQuest and I informed the public that our lash-conditioning product never had drugs or patent infringing ingredients in its formulation," said Sam Dhatt, owner of DermaQuest Skin Therapy. "I promptly submitted the complete ingredient list and all necessary paperwork to Allergan, Inc. to prove our innocence in this case and asked for prompt dismissal."

DermaLash was released in the skincare market mid-2007 as a drug-free alternative to some of the other lash conditioning products on the market. DermaQuest Skin Therapy's DermaLash contains ingredients from naturally-derived sources to strengthen and condition the lashes such as copper, biotin and amino acids. "I am pleased to have the case dropped against DermaQuest Skin Therapy so we can move forward with our business," says Dhatt. "We definitely do not want the negative press or to suffer financial loss from a case like this."

DermaLash Eyelash Growth Promoter Complex Ingredient List
Tussilago Farfara (Clotsfoot) Flower Extract, Achillea Millefolium Extract, Cinchona Succirubra Bark Extract, Alcohol Denat., Panthenyl Ethyl Ether, Milk Protein Lactose, Inositol, Acetyl Cysteine, Acetyl Methionine, Sodium Citrate, Citric Acid, PPG-26, Buteth-26, PEG-40 Hydrogenated Castor Oil, Apigenin, Oleanolic Acid, Biotinyl Tripeptide-1

About DermaQuest Skin Therapy
DermaQuest Skin Therapy was founded in 1999 by cosmetic scientist Sam Dhatt to create and market expertly formulated skin care products that deliver results. These results are realized from the high concentrations of performance ingredients which are formulated into each DermaQuest Skin Therapy product. All DermaQuest Skin Therapy products are developed, packaged and distributed from their own 65,000 square foot state-of-the-art facility in Hayward, CA and the products are sold to physicians and clinical professionals globally. DermaQuest Skin Therapy employs on-site chemists, which allows the immediate utilization of the latest advances in skin care as they are introduced into the marketplace. DermaQuest Skin Therapy products are paraben-free and they do not conduct animal testing. DermaQuest Skin Therapy continues to formulate new products as innovative ingredients and technologies are discovered.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Allyson Rogers
Visit website